2012. Evaluation of Invasion in Papillary Lesions. Outline of Talk. Outline of Talk. Overview of papillary lesions. Overview of papillary lesions

5/27/2012 Evaluation of Invasion in Papillary Lesions Yunn-Yi Chen, MD, PhD Professor Outline of Talk “We have struggled with this differential di...
Author: Ambrose Brooks
2 downloads 0 Views 5MB Size
5/27/2012

Evaluation of Invasion in Papillary Lesions

Yunn-Yi Chen, MD, PhD Professor

Outline of Talk

“We have struggled with this differential diagnosis (benign from malignant papillary lesions) in our laboratory of surgical pathology for many years, and we still find it to be probably the most difficult diagnostic problem that we face with breast neoplasms……And we check the accuracy of our diagnosis by very long-term follow-up of the patients.” --Dr. Cushman D. Haagensen, 1986

Outline of Talk

 Overview of papillary lesions

 Overview of papillary lesions

 Benign alterations in papilloma mimicking invasion

 Benign alterations in papilloma mimicking invasion

 Invasion arising in papillary DCIS

 Invasion arising in papillary DCIS

 What is “invasive papillary carcinoma”?

 What is “invasive papillary carcinoma”?

• Intracystic/encapsulated papillary carcinoma • Solid papillary carcinoma

• Intracystic/encapsulated papillary carcinoma • Solid papillary carcinoma

1

5/27/2012

Useful IHC markers for papillary lesions--

Classification of papillary lesions

p63, SMM and CK5/6

 Papilloma

 involved by non-atypical proliferative changes  involved by atypical hyperplasia (atypical papilloma)  involved by DCIS (DCIS arising in a papilloma)

Predominantly papillary

 Papillary DCIS  Intracystic/encapsulated papillary carcinoma  Solid papillary carcinoma  Invasive papillary carcinoma

Papilloma vs papillary carcinoma

Predominantly solid

Benign papilloma retains a continuous layer of ME cells along the fibrovascular cores P63 stain

2

5/27/2012

Papillary carcinoma lacks or has a paucity of ME cells along the fibrovascular cores

Solid papillary DCIS vs papilloma with florid UDH P63 stain

Solid papillary DCIS vs papilloma with florid UDH CK5/6 stain

Outline of Talk  Overview of papillary lesions  Benign alterations in papilloma mimicking invasion  Invasion arising in papillary DCIS  What is “invasive papillary carcinoma”?

Solid papillary DCIS

Papilloma with florid hyperplasia

• Intracystic/encapsulated papillary carcinoma • Solid papillary carcinoma

3

5/27/2012

Benign alterations in papilloma Potential diagnostic pitfalls

Sclerosis in papilloma/sclerosed papilloma

Sclerosis Infarct / Necrosis

Mimic Invasive Cancer

Epithelial Displacement Squamous metaplasia

Sclerosis in papilloma Pitfall: mimic invasive carcinoma, esp in core biopsy

Sclerosis in papilloma Myoepithelial markers confirm benign P63 stain

4

5/27/2012

Sclerosed papilloma-Sclerosed papilloma

distorted & angulated tubules in fibrotic stroma Pitfalls: Mask the papillary process, mimic invasion

Sclerosed papilloma

Infarct / necrosis in papilloma

Caution: ME markers may be reduced or focally absent in sclerosed papilloma

p63

SMM

CK5/6

5

5/27/2012

Infarct / necrosis in papilloma Pitfall: mimic invasive cancer, esp in a core biopsy

Pseudo-invasive growth in papilloma Settings:  After infarct  After duct rupture  After biopsy (epithelial displacement) Diagnostic clues favoring benign nature:  Granulation tissue  Hemosiderin  Cholesterol cleft  Squamous metaplasia  Myoepithelium

Squamous metaplasia in papilloma with pseudo-invasive growth Pitfall: - Mimic metaplastic carcinoma - ME markers or - in squamous metaplasia

Pseudo-invasive growth in papilloma  Myoepithelium is not always present  Caution advised in evaluating epithelium entrapped within inflamed granulation tissue  Caution advised in core biopsies Excision may be needed to exclude cancer

6

5/27/2012

Outline of Talk

“In practice, if a papillary tumour in the ductal lumen is judged to be benign, a nubbin of apparent infiltration of the wall can safely be disregarded, and is usually the result of the process described (pseudoinfiltration)” -- Professor John G. Azzopardi , 1979

 Overview of papillary lesions  Benign alterations in papilloma mimicking invasion  Invasion arising in papillary DCIS  What is “invasive papillary carcinoma”? • Intracystic/encapsulated papillary carcinoma • Solid papillary carcinoma

Invasion arising from papillary DCIS

DCIS involving sclerosed papilloma or sclerosis in papillary DCIS may mimic invasion

 When papillary intraductal carcinomas invade, they generally assume the pattern of infiltrating ductal carcinoma and lack a paillary architecture  Papillary DCIS with sclerosis: mimic invasion  ME marker may be attenuated in papillary DCIS

Avoid overDx of invasion

7

5/27/2012

Sclerosis in papillary DCIS may mimic invasion ME markers rule out invasion p63

IDC arising in association with papillary DCIS Note the patchy loss of ME marker in papillary DCIS

p63 stain

SMM

CK5/6

Outline of Talk  Overview of papillary lesions  Benign alterations in papilloma mimicking invasion  Invasion arising in papillary DCIS

Invasive papillary carcinoma (IPC)  Definition: An invasive carcinoma with predominantly papillary morphology  What are the pathologic features of IPC?  Is papillary carcinoma that lacks a peripheral layer of ME cells an IPC?

 What is “invasive papillary carcinoma”? • Intracystic/encapsulated papillary carcinoma • Solid papillary carcinoma

8

5/27/2012

Pure invasive papillary carcinoma  Incidence: 2.2 % (35/1603)

“stromal non-intraductal  Pathologic component was self-evident”  Circumscribed (2/3 cases)  Intermediate histologic grade  Associated papillary DCIS  Clinical  Non-Caucasian  Post-menopausal women  Lower incidence of + LN (32%)  Better survival, prognosis similar to pure tubular and mucinous ca “Unique histologic type of invasive mammary cancer with a favorable prognosis”

Examples of invasive papillary carcinoma from NSABP B04

Examples of invasive papillary carcinoma from NSABP B04

? Invasive micropapillary carcinoma

9

5/27/2012

Intracystic papillary carcinoma

Intracystic papillary carcinoma

Synonyms:

Definition:

Intracystic/encapsulated papillary carcinoma

 Encysted papillary carcinoma  Encapsulated papillary carcinoma  Papillary carcinoma in a large cystic space  Well circumscribed, surrounded by a fibrous wall  Special type of DCIS (WHO 2003)  Histology of papillary DCIS, except: Lacks peripheral myoepithelium

Intracystic/encapsulated papillary Carcinoma SMM

10

5/27/2012

Is intracystic papillary carcinoma invasive?

Encapsulated PC showing skeletal muscle invasion

Invaded Past Myoepithelium

Compressed Myoepithelium

? Invasive

In-situ

Controversial !

Encapsulated PC showing skeletal muscle invasion

Encapsulated PC showing vascular invasion

(case contributed by Dr. K. Che Prasad)

11

5/27/2012

Mammary papillary carcinoma metastatic to lung (h/o DCIS 10 years ago, s/p mastectomy)

(case contributed by Dr. Jeffrey A. McDavit)

Intracystic/encapsulated papillary carcinoma:

Intracystic papillary carcinoma

an invasive tumor with circumscribed growth and excellent prognosis

Synonyms:

Definition: AJSP 2011

Clinical:

 Encysted papillary carcinoma  Encapsulated papillary carcinoma  Papillary carcinoma in a large cystic space  Well circumscribed, surrounded by a fibrous wall  Special type of DCIS (WHO 2003)  Histology of papillary DCIS, except: Lacks peripheral myoepithelium  6th-7th decades  Adjacent conventional in situ or invasive ca may be present If pure: Behavior mostly similar to DCIS, with rare cases of nodal metastases, local recurrence, and skeletal muscle invasion

12

5/27/2012

Solid papillary carcinoma Encapsulated papillary ca with adjacent IDC, NOS

EPC

IDC

IDC

EPC

(courtesy of Dr. Dean Fong)

Solid papillary carcinoma Definition:

Solid papillary carcinoma

 Papillary carcinoma with a solid growth pattern  Well-circumscribed, single or multiple nodules  Special histologic and IHC features  Heterogeneous: Myoepithelium may be + or -

13

5/27/2012

Histologic features of solid papillary carcinoma

Histologic features of solid papillary carcinoma Mucinous production

Plasmacytoid

Neuroendocrine differentiation

Spindle cells Pseudo-rosette around cores

Chromogranin stain

Some solid papillary carcinomas have intact myoepithelial layer

Some solid papillary carcinomas lack peripheral myoepithelium p63 stain

In situ SPC calponin

14

5/27/2012

SPC as one single large nodule SPC: one single large nodule, no ME layer

p63 stain

Features suggestive of invasion in SPC SPC with multiple nodules, no ME layer

 Large tumor size  Complex, irregular, coalescent papillary nodules/nests SMM

 Irregular tumor-stromal interface  Encircling large blood vessels  Entrapment of benign ducts and lobules

15

5/27/2012

SPC-- large tumor size

SPC--complex, irregular, coalescent papillary nests

3.5 cm, well-circumscribed mass

Tumor-stromal interface in papillary carcinoma

SPC--irregular tumor-stromal interface

Invasive PC

Adjacent papillary DCIS

Irregular vs smooth

p63 stain

16

5/27/2012

SPC encircling large blood vessels

Features suggestive of invasion in SPC

PC showing entrapment of normal ducts and lobules

SPC showing stromal invasion

 Large tumor size  Complex, irregular, coalescent papillary nodules/nests  Irregular tumor-stromal interface  Encircling large blood vessels  Entrapment of benign ducts and lobules  Invading stroma/fat or skeletal muscle

17

5/27/2012

SPC showing LN metastasis

Features suggestive of invasion in SPC

Metastatic ca in LN with SPC pattern

 Large tumor size  Complex, irregular, coalescent papillary nodules/nests  Irregular tumor-stromal interface  Encircling large blood vessels

SPC in breast

 Entrapment of benign ducts and lobules  Invading stroma/fat and skeletal muscle  Metastatic disease

with same solid papillary growth

SPC showing LN metastasis

Metastatic ca in LN with SPC pattern

Solid papillary carcinoma Definition:

SPC in breast

Clinical:

 Papillary carcinoma with a solid growth pattern  Well-circumscribed, single or multiple nodules  Special histologic and IHC features  Heterogeneous: Myoepithelium may be + or -

 6th-7th decades  Adjacent conventional invasive ca may be present often mucinous or neuroendocrine-like

If pure and lack myoepithelium Indolent behavior Low rate of LN metastasis

18

5/27/2012

Approach for evaluating papillary carcinoma

Tumor with fibrovascular cores lined by epithelial cells

Tumor with fibrovascular cores lined by epithelial cells

IHC markers (p63, SMM, ± CK5/6): evaluate malignancy and invasion

UCSF approach for evaluating papillary carcinoma

Exclude benign papillary lesions ++ ME cells along papillae, + CK5/6

+ ME cells

+ ME cells

- ME cells, - CK5/6

Exclude benign papillary lesions ++ ME cells along papillae, + CK5/6

IHC markers (p63, SMM, ± CK5/6): evaluate malignancy and invasion

- ME cells, - CK5/6

In situ papillary ca - ME cells along papillae, - CK5/6 + ME cells at periphery of space

In situ papillary ca - or ME cells along papillae, - CK5/6 + ME cells at periphery of space

Circumscribed Solid papillary ca: Circumscribed nodule of PC with a solid papillary growth pattern and a smooth tumorstromal interface

Encapsulated/circumscribed papillary ca: Circumscribed nodule of PC in a dilated cystic space, with a thick fibrous capsule

UCSF approach for evaluating papillary carcinoma Dx: Encapsulated/circumscribed PC or SPC; see comment.

Comment: The tumor has a well-circumscribed border, but lacks a peripheral myoepithelial layer. These lesions likely represent a very low-grade invasive tumor with an expansile growth pattern and an excellent prognosis. The incidence of local recurrence or nodal metastasis is low and incidence of distant metastasis or cancer-related death is extremely low.

Tumor with fibrovascular cores lined by epithelial cells

IHC markers (p63, SMM, ± CK5/6): evaluate malignancy and invasion

Exclude benign papillary lesions ++ ME cells along papillae, + CK5/6 + ME cells

- ME cells, - CK5/6

In situ papillary ca - ME cells along papillae, - CK5/6 + ME cells at periphery of space

Invasive papillary ca: Carcinoma with predominantly papillary morphology with features of stromal invasion

19

5/27/2012

UCSF approach for evaluating papillary carcinoma Dx: Invasive PC; see comment.

Comment: Invasive papillary carcinoma is a special type of invasive carcinoma with a favorable prognosis. These tumors are associated with a low risk of LN metastasis and infrequent development of distant recurrence.

Tumor with fibrovascular cores lined by epithelial cells

+ ME cells

- ME cells, - CK5/6

Encapsulated/circumscribed papillary ca: Circumscribed nodule of PC in a dilated cystic space, with a thick fibrous capsule

ME-negative papillary ca (EPC, SPC and IPC) IDC: 0.7 cm

Older women

Exclude benign papillary lesions ++ ME cells along papillae, + CK5/6

IHC markers (p63, SMM, ± CK5/6): evaluate malignancy and invasion

Circumscribed solid papillary ca: Circumscribed nodule of PC with a solid papillary growth pattern and a smooth tumorstromal interface

In situ papillary ca - ME cells along papillae, - CK5/6 + ME cells at periphery of space

Invasive papillary ca: Carcinoma with predominantly papillary morphology with features of stromal invasion

When encapsulated/circumscribed PC associated with conventional invasive ca

EPC: 2.1 cm

 ER +, PR +, HER2 –  Favoralbe prognosis, low rate of LN metastasis  Less genomic changes than ER & grade-matched IDC  Genomic profile remarkably similar in the 3 morphologic subtypes of PC

Dx: 1. IDC, 0.7 cm; see comment 2. Encapsulated papillary ca, 2.1 cm 3. pT1b  Tumor type and stage based on nonpapillary invasive component  Report: associated with EPC, size, for clinical and imaging correlation

Duprez R et al: J Pathol 2012 Eberle C et al: USCAP abstract 2012

20

5/27/2012

Pure encapsulated/circumscribed PC without conventional invasive ca

Invasive papillary carcinoma

 No consensus in staging  Use the size of the lesion for pT

 UCSF: Tx or Tis with a comment

 Comment about special type of invasive carcinoma with a favorable prognosis

 Avoid overtreatment, but understand potential low rate of recurrence and metastasis

Management for pure ME-negative papillary ca (I)

Management for pure ME-negative papillary ca (II)

 Matter of debate

 ? SLN sampling

 appropriate for those with frankly invasive growth pattern

 Avoid overtreatment  Overall, manage similar to DCIS  Adequate local control: appropriate treatment

Pal SK et al: Breast Cancer Res Treat 2010 Rakha E et al: AJSP 2011

 ? Hormonal therapy (probably yes)  ? Radiation therapy  Chemotherapy not appropriate

Pal SK et al: Breast Cancer Res Treat 2010 Rakha E et al: AJSP 2011

21

5/27/2012

Take home message

Acknowledgement

 Alterations in benign papilloma may mimic invasion

 UCSF residents/fellows: beautiful gross photos

 ME markers may be in various benign papillary lesions and in papillary DCIS

 Contributing pathologists: challenging cases and wonderful gross photos

 Avoid overdiagnosis of invasion, especially with a benign papilloma background and in CNB  ME-negative “intracystic” papillary carcinoma and solid papillary carcinoma are likely low-grade invasive tumors  Conservative management for ME-negative papillary carcinoma

Selected references        

Collins LS et al: Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 2008;52:20-29. Duprez R et al: Immunophenotypic and genomic characterization of papillary carcinoma of the breast. J Pathol 2012;226:427-441. Koerner F. Papilloma and papillary carcinoma. Semin Diagn Pathol 2010;27:13-30. Nassar H et al: Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 2006;30:501-507. Pal SK et al: Papillary carcinoma of the breast: an overview. Breast Cancer Res Treat 2010;122:637-645. Rakha EA et al: Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol 2011;35:1093-1103. Ueng et al: Papillary neoplasm of the breast. A review. Arch Pathol Lab Med 2009;133:893-907. Wynveen CA et al: Intracystic papillary carcinoma of the breast. An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up. Am J Surg Pathol 2011;35:1-14.

22

Suggest Documents